Searched for
FRENCH PHARMACEUTICAL COMPANY
Sitharaman urges French firms to invest in India's AI, clean energy pushUnion Finance Minister Nirmala Sitharaman urged French businesses to boost investments in India, highlighting vast opportunities in AI, cle...
India Inc's green transition triggers hiring surgeAs organisations step up their sustainability efforts, demand is also growing for senior leadership talent, including business heads for re...
Global drugmakers rush to boost US presence as tariff threat loomsGlobal drug companies are boosting U.S. production and stockpiling medicines. This is a response to potential tariffs on branded drugs. Com...
How an Australian connection helped Shaily Mehrotra build a Rs 1,500-crore Indian skincare brandA gap in science-backed skincare products in the Indian market prompted Shaily Mehrotra to start Fixderma, with an aim to solve common skin...
Ahead of Market: 10 things that will decide stock market action on TuesdayThe Nifty 50 and BSE Sensex rebounded on broad-based buying led by pharma, IT, auto and metals. Volatility eased, while analysts signalled ...
Drug companies to pay Hawaii USD 700 million to settle Plavix blood thinner lawsuitPharmaceutical companies Bristol Myers Squibb and Sanofi have agreed to pay Hawaii USD 700 million to settle a lawsuit concerning the blood...
HCLTech chairperson Roshni Nadar Malhotra awarded France’s highest civilian honourHCLTech chairperson Roshni Nadar Malhotra receives France's highest civilian honor for outstanding service and promoting economic ties betw...
Lupin to acquire French firm Medisol for around Rs 160 crPharmaceuticals firm Lupin Ltd on Friday said it will fully acquire French pharmaceutical company Medisol for 18 million euros (over Rs 160...
Biogen appoints ex-Sinofi boss Christopher Viehbacher as its next CEO. Here are the detailsAfter a month gap in choosing the new CEO after Michel Vounatsos, Biogen has finally named Christopher Viehbacher as its new CEO.
Lupin completes acquisition of portfolio of brands from Anglo-French Drugs & Industries"India is critical in shaping Lupin's growth story going forward. This acquisition strengthens our position in the Indian market, where we ...
Investment firm behind scandal-hit NSO to be liquidatedIsraeli Defence Minister Benny Gantz was due to leave Wednesday for Paris, where he is set to discuss the scandal with his French counterpa...
Sanofi to produce Moderna coronavirus vaccineThe French pharmaceutical company Sanofi will help manufacture the Moderna coronavirus vaccine beginning in September, joining other compan...
Paris court convicts, fines French pharmaceutical company for deadly diet pillThe huge trial was spread over 10 months in 2019 and 2020, and nearly 400 lawyers worked on the case. Exceptionally, the Paris tribunal was...
GST will be catalyst for investment inflows: Christophe Sirugue, French MoS for Industry"Make in India programme offers tremendous opportunities for French companies, which have understood this well and incorporated it in their...
- Glenmark gets $25 mn from Sanofi as final upfront payment
Glenmark Pharmaceuticals today said it has received Rs 110 crore from Sanofi, as second tranche of oulicensing fee for a deal with French d...
- EU officials raid Ranbaxy French unit
Ranbaxy's French unit has been raided by European antitrust officials as part of a probe on cozy drug settlements which allegedly delay the...
- Indian pharma cos relying on local talent for overseas operations
Indian pharmaceutical companies are relying on local talent to head their overseas operations.
- Wockhardt gets a leg-up in Europe
Wockhardt’s latest acquisition expands its footprint in Europe. Wockhardt will pay $265 million (Rs 1,090 crore) in cash to acquire Negma L...
- Wockhardt buys French co for Rs 1,090 cr
Wockhardt has acquired Negma Laboratories in cash - a deal that would give it access to the European mkt.
- French AMC plans local fund
French global asset management company (AMC) Shanti Gestion, is looking to launch a fund for investing in Indian companies with high growth...